Literature DB >> 2385560

Recurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung.

M N Shaukat1, P Hughes.   

Abstract

A case of adenocarcinoma of the lung, in which high titre anticardiolipin antibodies were associated with recurrent venous thromboses resistant to all forms of therapy, is described. It is suggested that such an autoimmune response may be a contributory factor in the para-neoplastic development of vascular thromboses.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2385560      PMCID： PMC2429403          DOI： 10.1136/pgmj.66.774.316

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  23 in total

1.  The effect of intravenous infusion of thromboplastin on "heparin tolerance".

Authors:  R C HARTMANN; C L CONLEY; J R KREVANS
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808

2.  Lupus-type coagulation inhibitor in hairy cell leukaemia and resolution with splenectomy.

Authors:  A S Duncombe; R G Dalton; G F Savidge
Journal:  Br J Haematol       Date:  1987-01       Impact factor: 6.998

3.  Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.

Authors:  R G Malia; M Greaves; L M Rowlands; A C Lawrence; A Hume; N R Rowell; J Moult; C M Holt; N Lindsey; P Hughes
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

4.  Lung cancer, immune thrombocytopenia and the lupus inhibitor.

Authors:  C L Kozlowski; M J Johnson; D W Gorst; R F Willey
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

5.  Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

Authors:  F R Rickles; R L Edwards
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

6.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

7.  Anticardiolipin antibodies in autoimmune thrombocytopenic purpura.

Authors:  E N Harris; A E Gharavi; U Hegde; G Derue; S H Morgan; H Englert; J K Chan; R A Asherson; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

8.  Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.

Authors:  U Dührsen; D Paar; C Kölbel; A Boekstegers; U Metz-Kurschel; R Wagner; W Kirch; P Meusers; E König; G Brittinger
Journal:  Klin Wochenschr       Date:  1987-09-15

9.  Trousseau's syndrome. Devastating coagulopathy in the absence of heparin.

Authors:  W R Bell; N F Starksen; S Tong; J K Porterfield
Journal:  Am J Med       Date:  1985-10       Impact factor: 4.965

10.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245
View more
  3 in total

1.  [Coagulopathy resulting from lupus anticoagulant antibodies as a paraneoplastic phenomenon in renal cell carcinoma relapse].

Authors:  N Berdjis; M Meier; F Hoeppner; H Behrendt
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

2.  Analysis of blood coagulation indexes, thromboelastogram and autoantibodies in patients with recurrent pregnancy loss.

Authors:  Huizhen Yao; Yimei Ji; Yanru Zhou
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

3.  Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

Authors:  E Zuckerman; E Toubi; T D Golan; T Rosenvald-Zuckerman; E Sabo; Z Shmuel; D Yeshurun
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.